About Firm News
In the News
Lisa Dwyer comments on the FDA’s recent proposal to regulate lab-developed tests
October 5, 2023
| WSJ Pro Venture Capital

Go to the article

Related Capabilities
Special Matters & Government Investigations FDA & Life Sciences
Explore King & Spalding
a blue and green background
Capabilities
Special Matters & Government Investigations
Learn More
a blue and green background
Capabilities
FDA & Life Sciences
Learn More